Send Inquiry

Request To Call Back

DASATINIB TABLETS IP

Name: DASATINIB TABLETS IP
Brand: PATHGENE PHARMA DISTRIBUTORS
Price: 2000 INR
Availability: InStock

Price 2000 INR/ Bottle

Get a Price/Quote

MOQ : 10 Bottles

DASATINIB TABLETS IP Specification

Dosage Form
Tablet

Packaging Type
Box

Brand Name
DASATIB

Salt Composition
Dasatinib

Origin of Medicine
India

Indication
Chronic Myeloid Leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia

Pacakaging (Quantity Per Box)
30 Tablets

Life Span
See expiry on pack

Drug Type
Prescription Only

Ingredients
Dasatinib

Physical Form
Tablet

Function
Anticancer / Tyrosine Kinase Inhibitor

Recommended For
Chronic Myeloid Leukemia (CML)

Dosage
100 mg

Dosage Guidelines
As prescribed by physician

Suitable For
Adults

Quantity
30 Tablets

Storage Instructions
Store in a cool, dry place

Patient Category
Oncology patients

Prescription Required
Yes

Tablet Shape
Round

Tablet Color
White

Regulatory Compliance
IP standards

Intended Use
Targeted therapy

Common Side Effects
May include nausea

Administration Route
Oral

Release Type
Immediate release

Shelf Packaging
Carton box

DASATINIB TABLETS IP Trade Information

Minimum Order Quantity
10 Bottles

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Bottles Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About DASATINIB TABLETS IP

Get It Now: DASATIB (Dasatinib Tablets IP) offers first-string support in combating Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia. Featuring a grand, first-rate formulation and manufactured to strict IP standards, each round, white tablet delivers an immediate release for superior efficacy. Redeem this exceptional anticancer therapy at the prescribed dosage-100 mg for adults-packaged securely in a carton box of 30 tablets. As a tyrosine kinase inhibitor, DASATIB stands as a top choice for oncology patients. Prescription required. Markdown Applied!

Ideal Use & Application of DASATIB Tablets IP

DASATIB Tablets IP are suitable for use in adult oncology patients, specifically those diagnosed with Chronic Myeloid Leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Used as a targeted therapy, this formulation harnesses the power of dasatinib to inhibit cancer cell growth, offering reliable support within plant applications of cancer management. Apply strictly according to your healthcare provider's directions for optimal results and patient safety.

Domestic Market & Logistic Details for DASATIB Tablets IP

DASATIB Tablets IP are proudly supplied and traded across India's main domestic market. With a focus on quick dispatch and efficient drop-off, customers can expect timely order estimates and consistent supply ability. Packaging features a secure carton box that maintains product integrity during transit. Trust in streamlined distribution and responsive service for prompt delivery of every order.

FAQ's of DASATINIB TABLETS IP:

Q: How should DASATIB Tablets IP be administered for best results?

A: DASATIB Tablets IP should be taken orally, exactly as prescribed by your physician. Follow the recommended dosage guidelines and swallow the tablet whole with water.

Q: What are the common side effects associated with DASATIB Tablets IP?

A: Common side effects may include nausea. Always consult your healthcare provider for a full list of possible reactions and seek immediate advice if you experience any severe or unexpected symptoms.

Q: When should patients seek medical attention while using DASATIB Tablets IP?

A: Patients should promptly consult their physician if they notice severe side effects, allergic reactions, or any unusual symptoms during treatment with DASATIB Tablets IP.

Q: Where is DASATIB Tablets IP manufactured and supplied from?

A: DASATIB Tablets IP is manufactured and supplied from India, ensuring compliance with IP standards and regulatory guidelines.

Q: What is the benefit of selecting DASATIB Tablets IP for leukemia treatment?

A: DASATIB Tablets IP provides a targeted approach as a tyrosine kinase inhibitor, offering first-rate, effective management for Chronic Myeloid Leukemia and Philadelphia chromosome-positive ALL.

Q: How can one store DASATIB Tablets IP to maintain its effectiveness?

A: Store the tablets in a cool, dry place as indicated on the packaging to preserve their stability and potency. Always check the expiry date before use.

Tell us about your requirement